Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas.

Literature DB >> 201531

Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas.

R C Turner, L G Heding.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 1977 PMID： 201531 DOI： 10.1007/bf01236309

Source DB: PubMed Journal: Diabetologia ISSN： 0012-186X Impact factor: 10.122

× No keyword cloud information.

20 in total

1. Prolonged suppression of insulin release by insulin-induced hypoglycemia: demonstration by C-peptide assay.

Authors: D L Horwitz; A H Rubenstein; C Reynolds; G D Molnar; N Yanaihara
Journal: Horm Metab Res Date: 1975-11 Impact factor: 2.936

2. Human C-peptide in normal and diabetic subjects.

Authors: L G Heding; S M Rasmussen
Journal: Diabetologia Date: 1975-06 Impact factor: 10.122

3. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors: D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal: J Clin Invest Date: 1975-06 Impact factor: 14.808

4. Plasma proinsulin in patients with functioning pancreatic islet cell tumors.

Authors: B M Sherman; S Pek; S S Fajans; J C Floyd; J W Conn
Journal: J Clin Endocrinol Metab Date: 1972-08 Impact factor: 5.958

5. Letter: Insulin suppression.

Authors: D L Horwitz; A H Rubenstein
Journal: Lancet Date: 1974-10-26 Impact factor: 79.321

6. Diagnosis of insulinomas by suppression tests.

Authors: R C Turner; E Harris
Journal: Lancet Date: 1974-07-27 Impact factor: 79.321

7. Increased nerve-growth-stimulating activity in disseminated neurofibromatosis.

Authors: I Schenkein; E D Bueker; L Helson; F Axelrod; J Dancis
Journal: N Engl J Med Date: 1974-03-14 Impact factor: 91.245

8. Familial hyperproinsulinemia. An autosomal dominant defect.

Authors: K H Gabbay; K DeLuca; J N Fisher; M E Mako; A H Rubenstein
Journal: N Engl J Med Date: 1976-04-22 Impact factor: 91.245

9. Nonautonomous function of a pancreatic insulinoma.

Authors: E J Rayfield; M Pulini; A Golub; A H Rubenstein; D L Horwitz
Journal: J Clin Endocrinol Metab Date: 1976-12 Impact factor: 5.958

10. Proinsulin secretion by a pancreatic beta-cell adenoma. Proinsulin and C-peptide secretion.

Authors: F Melani; W G Ryan; A H Rubenstein; D F Steiner
Journal: N Engl J Med Date: 1970-10-01 Impact factor: 91.245

15 in total

1. Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians.

Authors: A Clark; M F Saad; T Nezzer; C Uren; W C Knowler; P H Bennett; R C Turner
Journal: Diabetologia Date: 1990-05 Impact factor: 10.122

2. Insulinoma producing progressive neurological deterioration over 30 years.

Authors: J A Snook; R vanderStar; R O Weller
Journal: Br Med J (Clin Res Ed) Date: 1986-07-26

3. Insulinoma: clinical manifestations, diagnosis and treatment. The significance of the prolonged fasting test and of the fasting blood glucose-insulin relationship.

Authors: K Johansen
Journal: J Endocrinol Invest Date: 1979 Jul-Sep Impact factor: 4.256

Review 9. Hypoglycemias.

Authors: F J Service
Journal: West J Med Date: 1991-04

10. Human Insulinomas: Clinical, Cellular, and Molecular Aspects.

Authors: Paul Komminoth; Philipp U. Heitz; Jürgen Roth
Journal: Endocr Pathol Date: 1999 Impact factor: 3.943